Apceth names chief business officer
This article was originally published in Scrip
Executive Summary
Cell therapy firm Apceth has appointed Dr Stefanos Theoharis to the newly created position of chief business officer. Prior to joining Munich, Germany-based Apceth – a developer of stem cell-based therapies for the treatment of malignant and non-malignant diseases – Dr Theoharis was head of business development at Antisense Pharma.